Dog /
FDA CVM · 2025 release 7,526 reports on file

Terrier - Boston - FDA Adverse Event Profile

Adverse-event records for Terrier - Boston (Dog) from the FDA Center for Veterinary Medicine.

Verify with FDA CVM →
Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 560 420 280 140 0 2018 2019 2020 2021 2022 2023 2024 2025 Reports filed Death-coded reports
Annual report volume for Terrier - Boston drawn from FDA CVM filings.

Data updated June 2026

The record at a glance

Among dog breeds, Terrier - Boston is #28 by FDA report volume; 4.6% of its 7,526 reports (345) were death-coded.

#28
most-reported dog breed
4.6%
death-coded report share
1,594
Vomiting - top reaction
5.7 yr
average age at report

Read report counts next to breed popularity: a bigger number often just means more owners and more vet visits.

Total Reports

7,526

FDA CVM filings

Deaths Reported

345

of 7,526 reports

Death Rate

4.6%

death-coded share

Avg Age at Report

5.7 yr

10.2 kg avg weight

Death-Coded Outcome Share

Terrier - Boston death-coded reports 4.6%
Cross-breed median

4.6% of 7,526 terrier - boston reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (about 4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Average weight at time of report: 10.2 kg (22.5 lbs)

Top Reported Reactions

Vomiting 1,594
Emesis 831
Lethargy (see also Central nervous system depression in 'Neurological') 674
Diarrhoea 550
Lack of efficacy (endoparasite) - hookworm 435
Lack of efficacy - NOS 403
Seizure NOS 370
Lack of efficacy (ectoparasite) - flea 316
INEFFECTIVE, HEARTWORM LARVAE 265
Anorexia 238
Digestive tract disorder NOS 237
Lack of efficacy (endoparasite) - heartworm 236
Other abnormal test result NOS 220
Elevated alanine aminotransferase (ALT) 213
Behavioural disorder NOS 184

Most Referenced Drugs

Milbemycin Oxime + Spinosad 1,571
Trilostane 646
Ivermectin + Pyrantel As Pamoate Salt 639
Spinosad 555
Moxidectin 431
Afoxolaner 371
Oclacitinib Maleate 365
Pyrantel Pamoate;Sarolaner 322
Fluralaner Chew Tablets 298
Milbemycin Oxime + Praziquantel 224
Fluralaner 13.64% 12-Week Chew 149
Carprofen 139
Sarolaner 131
Selamectin 119
Maropitant Citrate 117

Outcome Breakdown

Recovered/Normal
2,580 (37.2%)
Outcome Unknown
2,152 (31.0%)
Ongoing
1,608 (23.2%)
Recovered with Sequela
257 (3.7%)
Died
187 (2.7%)
Euthanized
158 (2.3%)

Gender Distribution

Female 3,694 (49.1%)
Male 3,669 (48.8%)
Unknown 145 (1.9%)
Mixed 18 (0.2%)

Reports by Year

Year Reports Trend
2010 298
2011 433
2012 618
2013 629
2014 594
2015 562
2016 517
2017 580
2018 479
2019 560
2020 451
2021 406
2022 370
2023 398
2024 379
2025 252

Terrier - Boston Pet Health Insights

Terrier - Boston accounts for 7,526 FDA adverse event reports, ranking #28 by volume among dog breeds, with 345 reports (4.6%) coded as a death outcome. Mean age at report: 5.7 years, average weight 10.2 kg (22.5 lbs).

Top reported signs: Vomiting (1,594), Emesis (831), Lethargy (see also Central nervous system depression in 'Neurological') (674). Most-referenced drug: Milbemycin Oxime + Spinosad (1,571 reports), followed by Trilostane (646) and Ivermectin + Pyrantel As Pamoate Salt (639).

Outcome coding on 6,942 status-recorded reports is dominated by Recovered/Normal (37.2%). Annual submissions ranged 2,010-2,025 across 16 years on file.

Dog Breeds With a Similar Report Volume

Frequently Asked Questions

How many FDA adverse event reports involve Terrier - Boston?
There are 7,526 adverse event reports involving Terrier - Boston in the FDA database, with 345 reports involving death (4.6% death rate). Terrier - Boston ranks #28 by report volume.
What are the most common adverse reactions reported for Terrier - Boston?
The most commonly reported adverse reactions for Terrier - Boston are Vomiting (1,594 reports), Emesis (831 reports), Lethargy (see also Central nervous system depression in 'Neurological') (674 reports), Diarrhoea (550 reports), Lack of efficacy (endoparasite) - hookworm (435 reports).
What drugs are most frequently associated with Terrier - Boston adverse events?
The drugs most frequently referenced in Terrier - Boston adverse event reports are Milbemycin Oxime + Spinosad (1,571 reports), Trilostane (646 reports), Ivermectin + Pyrantel As Pamoate Salt (639 reports), Spinosad (555 reports), Moxidectin (431 reports).
What is the average age of Terrier - Boston in adverse event reports?
The average age of Terrier - Boston at the time of adverse event reports is 5.7 years, with an average weight of 10.2 kg (22.5 lbs).
Does a high number of adverse event reports mean Terrier - Boston is unhealthy?
No. FDA adverse event reports are voluntarily submitted and do not prove causation. Popular breeds with more veterinary visits tend to have more reports. The data reflects reporting patterns, not actual incidence rates. Always consult a veterinarian for health decisions.
Where does this Terrier - Boston safety data come from?
All data comes from the FDA Center for Veterinary Medicine's adverse event reporting system. Pet owners, veterinarians, and manufacturers voluntarily submit reports about adverse events potentially linked to animal drugs and other products.

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. Breed figures are computed directly from FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.